Skip to main content
Donate

Albert Keung, PhD

The Keung Group has focused on developing the use of human cerebral organoids, derived from pluripotent stem cells, to model molecular and cellular features of Angelman syndrome.
Albert Keung, PhD headshot
Albert Keung, PhD

Board Member

Goodnight Distinguished Scholar, Associate Professor

North Carolina State University

Website

Email: ajkeung@ncsu.edu

Dr. Albert Keung is the Goodnight Distinguished Scholar and Associate Professor of Chemical and Biomolecular Engineering at North Carolina State University. His group applies synthetic biology approaches to advance knowledge and treatment of neuroepigenetic disorders. Their work includes engineering new models for Angelman syndrome research and therapeutic testing, and using human stem cell models to study neuroepigenetic mechanisms underlying neurodevelopmental disorders.

FAST Global Science Summit Presentations

Disclaimer

This website contains information for a broad audience and may include information on current and upcoming programs that are not yet approved or accessible The information provided is for general informational purposes only and is not intended as medical advice, diagnosis, or treatment. While FAST strives to provide accurate and up-to-date information, the content on this site may not always reflect the most current research or clinical guidelines. The inclusion of clinical trial information, treatments or specific healthcare providers does not imply endorsement, recommendation or guarantee of safety, efficacy, or availability. Reliance on any information provided by this website is solely at your own risk. FAST disclaims any liability for any errors or omissions in the information provided or for any decisions made based on this information. For personalized medical advice or specific health concerns including participation in any clinical trial, please consult a qualified healthcare professional.